Navigation Links
Bay Area BioEconomy Initiative Appoints Dr. Una Ryan as Chairwoman
Date:11/11/2013

SAN FRANCISCO, Nov. 11, 2013 /PRNewswire/ -- The Bay Area BioEconomy Initiative today announced that it has appointed Una Ryan, O.B.E., Ph.D.,D.Sc., as Chairwoman of the non-profit organization. The Bay Area BioEconomy Initiative is committed to fostering an atmosphere of innovation and providing the means to enhance a vibrant bioeconomy in the Bay Area.

(Logo: http://photos.prnewswire.com/prnh/20131111/NY14293LOGO)

"I am honored to lead this initiative to grow the Bay Area bioeconomy," said Dr. Ryan. "By bringing together our region's world-class academic research centers and medical centers, industry leaders, investors, and government and regulatory agencies, we can address some of the most critical challenges in healthcare and, ultimately, bring promising breakthroughs to patients more quickly and efficiently."

The Bay Area BioEconomy Initiative has established three strategic imperatives to improve human health, including increasing efficiency in clinical trials; accelerating the timeline of drug discovery, development and diagnosis in areas of significant unmet medical need; and expediting the implementation of innovative technological advances into the everyday practice of medicine.

"Dr. Ryan has a proven track record of establishing life science companies and building successful cross-sector collaborations focused on improving health through innovative solutions," said Tony Coles, M.D., Former Chairman & Chief Executive Officer of Onyx Pharmaceuticals, Inc. "As an industry leader and as an investor, her expertise makes her the ideal person to develop the Bay Area BioEconomy Initiative to establish multi-disciplinary collaborations, develop innovative funding approaches and increase engagement with government stakeholders."

Matthew Hudes, U.S. leader of Deloitte's biotechnology practice, which is providing pro-bono advisory services to the initiative, said Dr. Ryan's appointment and the effort it represents comes during a watershed moment in health care.

"The U.S. life sciences industry is on the verge of a fundamental shift related to data-driven medicine and the migration to a value-based payment model," said Hudes.  "Under Dr. Ryan's leadership, this innovative community can be at the forefront of this transformation by better cultivating the assets and talents we are fortunate to have in place."

In addition to her position as Chair of the Bay Area BioEconomy Initiative, Dr. Ryan is Managing Director of Golden Seeds, an investment firm that pursues above market returns through the empowerment of women entrepreneurs and the people who invest in them. She is a partner in Astia Angel, investing in women-led ventures as well as The Angel Forum, a group of CEOs and founders of entrepreneurial ventures who are now dedicated to investing in, mentoring and advising Silicon Valley startups.

"BayBio shares the Bay Area BioEconomy Initiative's commitment to strengthening our life science community," said Gail Maderis, President & CEO of BayBio, the industry organization representing and supporting Northern California's life science community.  "The Bay Area is fortunate to have Dr. Ryan's leadership on this important initiative."

Dr. Ryan is a Research Professor of Medicine at Boston University School of Medicine, and has authored over 500 publications in vascular biology. Her board positions include BayBio, Albany Molecular Research, RenovoRx and Bioarray Therapeutics. She previously served as chair of MassBio, and served on the board of Biotechnology Industry Organization, the Massachusetts Life Sciences Collaborative Leadership Council and Management Sciences for Health (MSH).  Dr. Ryan previously served as President and CEO of Diagnostics for All, President and CEO of Waltham Technologies, Inc., and President and CEO of AVANT Immunotherapeutics, Inc.

Dr. Ryan holds a Ph.D. in Cellular and Molecular Biology from Cambridge University, an Honorary Doctor of Science degree and Bachelor of Science degrees from Bristol University. In 2007, Dr. Ryan received the Albert Einstein Award for outstanding achievement in the life sciences. In 2002, Her Majesty Queen Elizabeth II awarded Dr. Ryan the Order of the British Empire (OBE) for services to biotechnology.

About the Bay Area BioEconomy Initiative
The Bay Area BioEconomy Initiative is a non-profit organization committed to fostering an atmosphere of innovation and providing the mean to enhance a vibrant BioEconomy in the Bay Area. Bay-BI has established three strategic imperatives to improve human health, including increasing efficiency in clinical trials; accelerating the timeline of drug discovery, development and diagnosis in areas of significant unmet medical need; and expediting the implementation of innovative technological advances into the everyday practice of medicine. Founding Bay-BI sponsors include Deloitte, Onyx Pharmaceuticals, Inc., BayBio, Agilent Technologies, Alta Partners, Bayer, BioCentury Publications, Inc., DLA Piper, Gladstone Institutes, Johnson and Johnson, Oncomed, Pfizer, Stanford University, University of California, San Francisco.

Media Contact
Paul Dunker
Deloitte Services LP
Tel: +1 614 229 4644
Cell: +1 614 448 7628
Email: pdunker@deloitte.com 

 


'/>"/>
SOURCE Deloitte
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Herborium Announces Continuing Progress In Key Strategic Initiatives
2. Uroplasty Announces Product Development and New Clinical Trial Initiatives
3. Kansas City Region Launches Contract Research Initiative To Speed The Development Of Health Care Innovation Worldwide
4. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
5. QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
6. Detroit Metro Convention & Visitors Bureau announces launch of Medical Meetings Initiative; recruits top leaders to Advisory Council
7. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
8. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
9. BioElectronics Corporation Announces Initiative for UK and German Markets
10. Duane Reade To Partner With Mission Electric On Green Transportation Initiative
11. China Health Resource Announces Go Global Initiative For New Product Introductions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 2016  The Parenteral Drug Association, Inc. (PDA), ... manufacturing sterile drug products, today announced the publication ... – With link to Comparison Spreadsheet. The ... U.S. FDA, the EU, the Pharmaceutical Inspection Convention/Scheme ... --> --> PDA,s Global Sterile ...
(Date:2/8/2016)... LONDON , Feb.8, 2016 Cardiovascular ... Summary GlobalData,s Medical Devices sector report, ... 2015" provides an overview of Cardiovascular Surgery Devices ... --> The report provides comprehensive ... of the products at various stages of development. ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... therapy products, announced today the introduction of the newly designed, innovative shoulder wrap. ... and better cold therapy coverage for the injured arm and shoulder to promote ...
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... i2i Systems, ... of the highest preliminary data vendors in the latest KLAS report, Population Health Management ... has led the developing market for population health management (PHM). The latest KLAS ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory ... federallabs.org . The site houses a wealth of federal resources that businesses can ... process called technology transfer (T2). As a network of over 300 federal laboratories, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The Valentine’s Season is famous for gift giving ... significant others that they are loved. This year, for more than 5.6 million Americans ... - just won't be enough to remind them of the lives they’ve led and the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... and clothing, announced expansion into Canada to provide its range of unique and ... sales office in Quebec City that will provide bilingual customer service and marketing ...
Breaking Medicine News(10 mins):